Collaborations & PartnershipsGlobalNF1NF2-SWNPress ReleaseSWN ANNOUNCING THE LAUNCH OF CHILDREN’S TUMOR FOUNDATION EUROPE
GlobalNF1Science & Research Selumetinib Granted Orphan Drug Designation by the European Medicines Agency